Member Info for Soupdragon78

Go on goup, tell us how NFX is involved in PH94b?

Next you’ll be telling us Vicks Nasal Spray is NFX involvement as well.

If your going to b/s at least make an effort.

Why would nfx be involved. Their scope was to find a cocrystal method of combining AV-101 and Probenecid.

PH94b has always been a nasal spray before NFX and Vistagen started their collaboration

Someone just sold up their 302,178 that they bought yesterday at a loss despite the rise. One day they’ll figure out to look at the spread.

Guess they’ll never learn.

Hopefully the boards continual use of the words ‘near-term’ comes to fruition over the next month, but it has to have meat on the bone in any rns, we are at the show me stage.

The trade deal won’t have much of an impact on NFX, the IP aspects are like most regulations still tied to EU decisions, they will continue to determine what uk companies can and can’t do as the deal syncs in with the Commissions 5 year cycle.

Maybe we can repeat the excitement of when flights to Japan started up again, remember when NFX were going to be first on board.

Looking forward to NFX deal news!

Indeed Halespur, what needs clarification is how this new pre-clinical differs from the previous pre-clinical done a couple of years ago. Hopefully its using the inhaled method.

Discussions vs. negotiations....

All rather quiet here today, some were excited about the possibility of two rns’ in one day.

One things for sure, they’re not that bothered about trying to generate some excitement here with the way the communicate.

Back to waiting.

And a new broker

More of the same.

Discussions ongoing. 2021 Q1 for funding of further work to NXP002. A bit quiet on nxp004

Because it’s not a Covid stock you clump.

Interims with NXP004 update, reckon they’ll say they’ve received all the pre-clinical data and are now evaluating.
Would be good to know if they’ve furthered the inhaler type as they’ve been doing that for over a year now.

Key week lined up not just for the company but for the promisers as well.

Hope everyone enjoys the festive week.

As long as they’re good it doesn’t matter if they are large or small.
The largest aren’t always the best.

Vistagen connected with NFX for them to try and find a cocrystal form of AV-101 and probenecid, we do not currently know whether they have been successful in that.

So whilst Vistagens funding money will go towards further development of AV-101 we cannot as yet know whether this will be with NFX on board or not.

“ We expect to seek additional capital to produce PH94B study material, conduct the PH94B pivotal Phase 3 clinical trials, produce additional AV-101 study material for future nonclinical and clinical studies, conduct AV-101 Phase 3-enabling toxicology studies, conduct pivotal Phase 3 clinical studies of AV-101 in MDD, conduct AV-101 Phase 2 studies in LID, MDD, NP and SI, produce PH10 study material and conduct a Phase 2b clinical trial of PH10 in MDD, acquire or license and conduct research and development of additional product candidates and to fund our internal operations”

Thats quite a leap of the imagination there jiving.